Kiitos Leino, taas vakuuttavasta yhteenvedosta. Ottaisiko Kela tuosta millään muotoa ns. onkeensa?
Huupposen slaidit ovat säälittävää asian kiertämistä. 10 vuoden tyhjäkäynti ja rahan poltto on mahdollista vain julkisella sektorilla, teollisuudessa olisi tullut kenkää jo vuoden jälkeen noilla olemattomilla suoritteilla.
Mutta osataan sitä maailmallakin nollatutkia. Justin Smith on blogannut seuraavan, mistä muutama ote tässä:http://www.statinnation.net/blog/2017/9/29/the-new-study-showing-everyone-needs-statinsRecently, most of the British media ran a story suggesting statins should be taken by millions of people in their 20s and 30s. The articles made statements such as:
“Millions of people in their 20s and 30s should be offered statins” Telegraph
“Statins DO work” Daily Mail
“Statins Cut Heart Deaths by 28%” The Times
Several of the reports made reference to a "new trial", running for 20 years and being the longest of its kind. In fact, the study they are referring to is WOSCOPS and this study was completed in 1995!
The WOSCOPS study included 6,595 men in the West of Scotland, with high cholesterol levels. During this five year study, 1.7% of people who were given the placebo died of heart disease, compared with 1.2% of those who were given the statin. And overall, the use of the statin increased the chances of still being alive after 5 years, from a 96% chance to a 97% chance.
Todella järisyttävä vaikuttavuus statiinilla, vai mitä? An interesting feature of the WOSCOPS study is that around 80% of the people included were current smokers or ex-smokers. It is well known that smoking drastically increases the risk for heart disease. In fact, the heart disease death rate is 80% higher in heavy smokers than in non-smokers. We also know that smoking causes inflammation and this inflammation can take 5 years to return to normal levels after smoking has been stopped.
Näin niitä haluttuja tutkimustuloksia tehdään. Ilman temppuja olisi tullut käänteisiä tuloksia?In 2007, a follow-up study of WOSCOPS was published in the New England Journal of Medicine. For this, researchers undertook a 10 year follow up of the trial participants. There are a number of problems with this follow-up. After the original WOSCOPS trial had ended
some of the people who were in the placebo group started taking a statin, and some of those who were in the statin group stopped taking the drug. The researchers did not take account of this in the WOSCOPS follow up study. This means that any results obtained 10 years on are meaningless. The original groups were now mixed with some taking a statin and others not taking one.
To make matters worse, the researchers did not know how many people were taking statins after 5 years – the follow up period was 10 years but they only had data on this aspect for the first 5 years.
Uudelleen lämmitettyä soppaa, ja puurot sekä vellit siis ihanasti sekaisin. Onko tällainen lääke"tiedettä"? Tällä kuitenkin yritetään perustella statinoinnin aloittamista entistä nuoremmille.